Taken together, results of our study suggest that endotoxin and LBP plasma levels are strongly related to proinflammatory changes even in the early stages of NAFLD, while sCD14 levels seem to be associated with markers of insulin resistance. This evidence concerns the gene LBP and metabolic dysfunction-associated steatotic liver disease.